Log in to your Inderes Free account to see all free content on this page.
Acarix
0.31 SEK
+1.81 %
Less than 1K followers
ACARIX
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+1.81 %
+15.92 %
+3.17 %
+28.96 %
+23.31 %
+16.79 %
+10.05 %
-77.64 %
-95.81 %
Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary artery disease. The company's product is a non-invasive test that is applied with a patch to the patient to analyze sounds from the heart. The business is conducted primarily within the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The headquarters are located in Malmö.
Read moreMarket cap
347.67M SEK
Turnover
158.28K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12.2.
2026
Annual report '25
All
Press releases
ShowingAll content types
Acarix Publishes Interim Report, Third quarter 2025
Announcement from the general meeting in Acarix AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio